Biohaven Pharmaceutical Stock Forward View - Accumulation Distribution
| BHVN Stock | USD 11.36 0.14 1.22% |
Biohaven Stock outlook is based on your current time horizon. Although Biohaven Pharmaceutical's naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Biohaven Pharmaceutical's systematic risk associated with finding meaningful patterns of Biohaven Pharmaceutical fundamentals over time.
As of today the rsi of Biohaven Pharmaceutical's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (1.49) | EPS Estimate Current Year (5.52) | EPS Estimate Next Year (2.88) | Wall Street Target Price 20.9375 | EPS Estimate Current Quarter (1.61) |
Using Biohaven Pharmaceutical hype-based prediction, you can estimate the value of Biohaven Pharmaceutical Holding from the perspective of Biohaven Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Biohaven Pharmaceutical using Biohaven Pharmaceutical's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Biohaven using crowd psychology based on the activity and movement of Biohaven Pharmaceutical's stock price.
Biohaven Pharmaceutical Short Interest
An investor who is long Biohaven Pharmaceutical may also wish to track short interest. As short interest increases, investors should be becoming more worried about Biohaven Pharmaceutical and may potentially protect profits, hedge Biohaven Pharmaceutical with its derivative instruments, or be ready for some potential downside.
200 Day MA 13.9235 | Short Percent 0.1712 | Short Ratio 6.71 | Shares Short Prior Month 20 M | 50 Day MA 11.4116 |
Biohaven Relative Strength Index
Biohaven Pharmaceutical Hype to Price Pattern
Investor biases related to Biohaven Pharmaceutical's public news can be used to forecast risks associated with an investment in Biohaven. The trend in average sentiment can be used to explain how an investor holding Biohaven can time the market purely based on public headlines and social activities around Biohaven Pharmaceutical Holding. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Biohaven Pharmaceutical's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Biohaven Pharmaceutical.
Biohaven Pharmaceutical Implied Volatility | 1.28 |
Biohaven Pharmaceutical's implied volatility exposes the market's sentiment of Biohaven Pharmaceutical Holding stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Biohaven Pharmaceutical's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Biohaven Pharmaceutical stock will not fluctuate a lot when Biohaven Pharmaceutical's options are near their expiration.
Biohaven Pharmaceutical after-hype prediction price | USD 11.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Biohaven Pharmaceutical to cross-verify your projections. Prediction based on Rule 16 of the current Biohaven contract
Based on the Rule 16, the options market is currently suggesting that Biohaven Pharmaceutical Holding will have an average daily up or down price movement of about 0.08% per day over the life of the 2026-04-17 option contract. With Biohaven Pharmaceutical trading at USD 11.36, that is roughly USD 0.009088 . If you think that the market is fully incorporating Biohaven Pharmaceutical's daily price movement you should consider acquiring Biohaven Pharmaceutical Holding options at the current volatility level of 1.28%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Biohaven Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Biohaven Pharmaceutical's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Biohaven Pharmaceutical's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Biohaven Pharmaceutical stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Biohaven Pharmaceutical's open interest, investors have to compare it to Biohaven Pharmaceutical's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Biohaven Pharmaceutical is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Biohaven. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Biohaven Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Biohaven price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biohaven using various technical indicators. When you analyze Biohaven charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 68043.88 | 0.0498 |
| Check Biohaven Pharmaceutical Volatility | Backtest Biohaven Pharmaceutical | Information Ratio |
Biohaven Pharmaceutical Trading Date Momentum
| On February 15 2026 Biohaven Pharmaceutical Holding was traded for 11.36 at the closing time. The top price for the day was 11.85 and the lowest listed price was 11.26 . There was no trading activity during the period 0.0. Lack of trading volume on February 15, 2026 did not affect price variability. The overall trading delta against the current closing price is 1.23% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Biohaven Pharmaceutical to competition |
Other Forecasting Options for Biohaven Pharmaceutical
For every potential investor in Biohaven, whether a beginner or expert, Biohaven Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Biohaven Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Biohaven. Basic forecasting techniques help filter out the noise by identifying Biohaven Pharmaceutical's price trends.Biohaven Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biohaven Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Biohaven Pharmaceutical could also be used in its relative valuation, which is a method of valuing Biohaven Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Biohaven Pharmaceutical Market Strength Events
Market strength indicators help investors to evaluate how Biohaven Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biohaven Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Biohaven Pharmaceutical stock market strength indicators, traders can identify Biohaven Pharmaceutical Holding entry and exit signals to maximize returns.
Biohaven Pharmaceutical Risk Indicators
The analysis of Biohaven Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Biohaven Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biohaven stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.04 | |||
| Semi Deviation | 3.5 | |||
| Standard Deviation | 5.45 | |||
| Variance | 29.72 | |||
| Downside Variance | 14.09 | |||
| Semi Variance | 12.23 | |||
| Expected Short fall | (5.13) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Biohaven Pharmaceutical
The number of cover stories for Biohaven Pharmaceutical depends on current market conditions and Biohaven Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biohaven Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biohaven Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Biohaven Pharmaceutical Short Properties
Biohaven Pharmaceutical's future price predictability will typically decrease when Biohaven Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biohaven Pharmaceutical Holding often depends not only on the future outlook of the potential Biohaven Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biohaven Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 91.2 M | |
| Cash And Short Term Investments | 486 M |
Check out Historical Fundamental Analysis of Biohaven Pharmaceutical to cross-verify your projections. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Will Biotechnology sector continue expanding? Could Biohaven diversify its offerings? Factors like these will boost the valuation of Biohaven Pharmaceutical. Projected growth potential of Biohaven fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Biohaven Pharmaceutical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Biohaven Pharmaceutical requires distinguishing between market price and book value, where the latter reflects Biohaven's accounting equity. The concept of intrinsic value - what Biohaven Pharmaceutical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Biohaven Pharmaceutical's price substantially above or below its fundamental value.
It's important to distinguish between Biohaven Pharmaceutical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biohaven Pharmaceutical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biohaven Pharmaceutical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.